Droplet Digital PCR (ddPCR) has emerged as a powerful, sensitive, and cost-effective technology for circulating tumor DNA (ctDNA) analysis, enabling applications from early cancer detection to minimal residual disease (MRD)...
This article provides a comprehensive overview of strategies for optimizing binding affinity in anticancer drug design, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive analysis for researchers and drug development professionals on enhancing the accuracy of machine learning (ML) models in cancer detection.
Molecular dynamics (MD) simulation has become an indispensable tool in cancer drug discovery, providing atomic-level insights into drug-target interactions.
Tumor spatial heterogeneity—the variation in cellular composition, genetics, and function across different regions of a tumor—is a fundamental driver of therapeutic resistance and cancer progression.
This article provides a comprehensive analysis of emerging strategies to improve the sensitivity of PCR-based methods for early cancer detection and monitoring.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing antimicrobial dosing schedules to suppress resistance development.
This article provides a comprehensive guide to the workflow of mathematical modeling for optimizing cancer treatment, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive technical overview of digital PCR (dPCR) methodologies for analyzing circulating tumor DNA (ctDNA), a cornerstone of liquid biopsy in precision oncology.
Next-generation sequencing (NGS) has fundamentally transformed oncology, enabling comprehensive genomic profiling that drives precision medicine.